Carcinoma nasofaringeo: epidemiologia, diagnosi, stadiazione, trattamento tra presente e futuro

[Oncoinfo – Oncology Snapshots: follow us on http://oncoinfo.it] Many unanswered questions remain regarding nasopharyngeal carcinoma. First of all, what are the numbers in Italy, and what is the typical patient phenotype? What are the symptoms to watch for, and how is an accurate and early diagnosis made? How is the tumor correctly staged? What are the current standard treatment options for recurrent or metastatic nasopharyngeal carcinoma? And looking to the near future in Italy, what new therapies are emerging for the treatment of metastatic disease? Paolo Bossi (Head of Medical Oncology, Head and Neck Tumors, and Squamous and Basal Cell Skin Cancers at the Humanitas Cancer Center in Rozzano) answers all these questions. We met him at the AIOM 2025 congress in Rome.